PT91597A - Process for treating cutaneous lesions using antagonists of thea2 tromboxan receiver - Google Patents

Process for treating cutaneous lesions using antagonists of thea2 tromboxan receiver

Info

Publication number
PT91597A
PT91597A PT91597A PT9159789A PT91597A PT 91597 A PT91597 A PT 91597A PT 91597 A PT91597 A PT 91597A PT 9159789 A PT9159789 A PT 9159789A PT 91597 A PT91597 A PT 91597A
Authority
PT
Portugal
Prior art keywords
tromboxan
thea2
antagonists
receiver
cutaneous lesions
Prior art date
Application number
PT91597A
Other languages
English (en)
Other versions
PT91597B (pt
Inventor
Lawrence T Friedhoff
Laura L Bolton
Original Assignee
Squibb & Sons Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Squibb & Sons Inc filed Critical Squibb & Sons Inc
Publication of PT91597A publication Critical patent/PT91597A/pt
Publication of PT91597B publication Critical patent/PT91597B/pt

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/557Eicosanoids, e.g. leukotrienes or prostaglandins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Dermatology (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Financial Or Insurance-Related Operations Such As Payment And Settlement (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Measuring Pulse, Heart Rate, Blood Pressure Or Blood Flow (AREA)
PT91597A 1988-09-01 1989-08-31 Processo para tratar lesoes cutaneas usando antagonistas do receptor de tromboxano a2 como o 7-oxabiciclo-{2.2.1}hept-2-1}5-heptenoico PT91597B (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/239,376 US4925873A (en) 1988-09-01 1988-09-01 Method of treating skin injuries using thromboxane A2 receptor antagonists

Publications (2)

Publication Number Publication Date
PT91597A true PT91597A (pt) 1990-03-30
PT91597B PT91597B (pt) 1995-05-04

Family

ID=22901897

Family Applications (1)

Application Number Title Priority Date Filing Date
PT91597A PT91597B (pt) 1988-09-01 1989-08-31 Processo para tratar lesoes cutaneas usando antagonistas do receptor de tromboxano a2 como o 7-oxabiciclo-{2.2.1}hept-2-1}5-heptenoico

Country Status (13)

Country Link
US (1) US4925873A (pt)
EP (1) EP0357030B1 (pt)
JP (1) JPH02108635A (pt)
AT (1) ATE100320T1 (pt)
AU (1) AU632503B2 (pt)
CA (1) CA1337930C (pt)
DE (1) DE68912459T2 (pt)
DK (1) DK175207B1 (pt)
HU (1) HUT51137A (pt)
IE (1) IE63799B1 (pt)
NZ (1) NZ230505A (pt)
PT (1) PT91597B (pt)
ZA (1) ZA896558B (pt)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6313146B1 (en) 1991-08-23 2001-11-06 Nps Pharmaceuticals, Inc. Calcium receptor-active molecules
US5858684A (en) * 1991-08-23 1999-01-12 The Brigham And Women's Hospital, Inc. Method of screening calcium receptor-active molecules
US6001884A (en) * 1991-08-23 1999-12-14 Nps Pharmaceuticals, Inc. Calcium receptor-active molecules
US5763569A (en) * 1991-08-23 1998-06-09 The Brigham And Women's Hospital, Inc Calcium receptor-active molecules
US6011068A (en) * 1991-08-23 2000-01-04 Nps Pharmaceuticals, Inc. Calcium receptor-active molecules
US5688938A (en) * 1991-08-23 1997-11-18 The Brigham & Women's Hospital, Inc. Calcium receptor-active molecules
US6031003A (en) * 1991-08-23 2000-02-29 Nps Pharmaceuticals, Inc. Calcium receptor-active molecules
US5324746A (en) * 1993-02-12 1994-06-28 Mckee Rex N Method of treating damaged mucosal and epithelial tissues with misoprostol
US5962314A (en) * 1993-02-23 1999-10-05 Nps Pharmaceuticals, Inc. Calcium receptor-active molecules
US7910624B1 (en) 1995-03-03 2011-03-22 The Trustees Of Boston University Compositions for the treatment of blood disorders
AU696167B2 (en) * 1993-10-29 1998-09-03 Trustees Of Boston University Physiologically stable compositions of butyric acid, and butyric acid salts and derivatives as anti-neoplastic agents
CA2202879C (en) 1994-10-21 2005-08-30 Bradford C. Van Wagenen Calcium receptor-active compounds
GB9424708D0 (en) * 1994-12-07 1995-02-01 Bristol Myers Squibb Co Use of inflammatory modulators in the treatment of chronic or recalcitrant skin damage
US6011000A (en) * 1995-03-03 2000-01-04 Perrine; Susan P. Compositions for the treatment of blood disorders
ES2201300T3 (es) * 1996-05-01 2004-03-16 Nps Pharmaceuticals, Inc. Compuestos activos frente a receptores de iones inorganicos.
US5994399A (en) * 1997-03-27 1999-11-30 Mckee; Rex N. Method of regenerating collagen-containing tissues with misoprostol
WO1999040883A2 (en) * 1998-02-11 1999-08-19 Faller Douglas V Compositions and methods for the treatment of cystic fibrosis
US7241746B2 (en) * 2003-08-06 2007-07-10 Regena Therapeutics, Lc Method and composition for treating periodontal disease
WO2010105112A1 (en) * 2009-03-11 2010-09-16 Hemaquest Pharmaceuticals, Inc. Detection of short-chain fatty acids in biological samples
US20110086869A1 (en) 2009-09-24 2011-04-14 The Trustees Of Boston University Methods for treating viral disorders
WO2011072086A1 (en) 2009-12-08 2011-06-16 Hemaquest Pharmaceuticals, Inc. Methods and low dose regimens for treating red blood cell disorders
WO2011113013A2 (en) 2010-03-11 2011-09-15 Hemaquest Pharmaceuticals, Inc. Methods and compositions for treating viral or virally-induced conditions
WO2012105823A1 (en) 2011-02-02 2012-08-09 Biotropics Malaysia Berhad Cosmetic non therapeutic use of extracts from ficus deltoidea
JP2022536256A (ja) 2019-05-31 2022-08-15 ヴィラクタ サブシディアリー,インク. ヒストンデアセチラーゼ阻害剤を用いてウイルス関連癌を治療する方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2809377A1 (de) * 1978-03-04 1979-09-13 Boehringer Mannheim Gmbh Phenoxyalkylcarbonsaeure-derivate, verfahren zu deren herstellung sowie diese verbindungen enthaltende arzneimittel
US4311707A (en) * 1979-02-12 1982-01-19 American Cyanamid Company Process for topically producing cutaneous vasodilation for the treatment of vasospastic or ischemic conditions
DE3000377A1 (de) * 1980-01-07 1981-07-09 Boehringer Mannheim Gmbh, 6800 Mannheim Neue sulfonamide, verfahren zu deren herstellung sowie diese verbindungen enthaltende arzneimittel
US4537981A (en) * 1981-11-09 1985-08-27 E. R. Squibb & Sons, Inc. 7-Oxabicycloheptane and 7-oxabicycloheptene compounds
US4416896A (en) * 1982-05-17 1983-11-22 E. R. Squibb & Sons, Inc. 7-Oxabicyclopheptane substituted amino prostaglandin analogs useful in the treatment of thrombolytic disease
US4663336A (en) * 1985-07-01 1987-05-05 E. R. Squibb & Sons, Inc. 7-oxabicycloheptane substituted diamide and its congener prostaglandin analogs useful in the treatment of thrombotic disease
US4673685A (en) * 1986-07-23 1987-06-16 E. R. Squibb & Sons, Inc. Hydroximic acids of 7-oxabicycloheptane substituted ethers and thioethers useful in the treatment of thrombotic disease
US4752616A (en) * 1987-06-29 1988-06-21 E. R. Squibb & Sons, Inc. Arylthioalkylphenyl carboxylic acids, compositions containing same and method of use

Also Published As

Publication number Publication date
EP0357030A2 (en) 1990-03-07
DE68912459D1 (de) 1994-03-03
ATE100320T1 (de) 1994-02-15
AU632503B2 (en) 1993-01-07
ZA896558B (en) 1990-05-30
EP0357030B1 (en) 1994-01-19
JPH02108635A (ja) 1990-04-20
DK431589D0 (da) 1989-08-31
DK175207B1 (da) 2004-07-12
CA1337930C (en) 1996-01-16
US4925873A (en) 1990-05-15
DE68912459T2 (de) 1994-08-04
PT91597B (pt) 1995-05-04
AU4089889A (en) 1990-03-08
DK431589A (da) 1990-03-02
EP0357030A3 (en) 1990-08-16
NZ230505A (en) 1997-03-24
IE63799B1 (en) 1995-06-14
IE892755L (en) 1990-03-01
HUT51137A (en) 1990-04-28

Similar Documents

Publication Publication Date Title
PT91597A (pt) Process for treating cutaneous lesions using antagonists of thea2 tromboxan receiver
DE68929460D1 (de) Substituierte Phenylpyrimidine Derivate, für die Behandlung oder Prevention von ZNS-Erkrankungen
HU912359D0 (en) The use of flupirtine active agents for treating muscle-tension
ES2038609T3 (es) 4,5-dihidroisoxazol, 3,5 disustituido como inhibidores de transglutaminasa.
UA41355C2 (uk) Засіб для лікування нейро-сніду
ATE158183T1 (de) Arzneimittel zur behandlung von anxietas
DK71387A (da) Terapeutisk middel til behandling af psoriasis
DE58907570D1 (de) Verwendung von bicyclischen Imidazol-Verbindungen zur Behandlung von Hyperaldosteronismus.
US4931457B1 (en) Naphthylamino-and naphthyloxy-pyridineamin compounds useful as topical antiinflammatory agents for the treatment of skin disorders
ES2093357T3 (es) Metodo de tratamiento de la alopecia.
ES2180550T3 (es) Moleculas receptoras de la hormona de glycoproteina.
BR9406034A (pt) Derivados de imidazoloquinoxalinonas como antagonistas de eaa.
ES2145608T3 (es) El empleo de buckminster-fulereno para tratamiento de lesion neurotoxica.
DE68912376D1 (de) Analoge von Bradykinin, dessen Synthese und dessen Benutzung in der Therapie.
MX164619B (es) Composicion para el tratamiento de lesiones cutaneas
FI871535A0 (fi) Menetelmä terapeuttisesti aktiivisten tiasykloalkeno/3,2-b/pyridiinien valmistamiseksi
DK277387A (da) Terapeutisk topikal sammensaetning mod en hyperprolifererende epithelsygdom
LV10391A (lv) Alkilfosforskabes savienojumu izmantosana psoriazes tipa slimibu arstesanai
HU912638D0 (en) Transdermal medical device for entering medical active agents under controlled ph-conditions of the skin surface, and process for its production
DE3866860D1 (de) Thyrotropin abgebende hormonanaloge fuer verletzungen am zentralnervensystem.
ATE147983T1 (de) Transdermales therapeutisches system mit pentylentetrazol als wirkstoff
ES2190499T3 (es) Uso de antagonistas de bradiquinina para la preparacion de medicamentos para el tratamiento y la prevencion de la enfermedad de alzheimer.
FI97884B (fi) Menetelmä uusien terapeuttisesti käyttökelpoisten 3,4-dihydroksi-2,5-dihydrofuranonien valmistamiseksi
ATE102828T1 (de) Verwendung von calciumantagonisten fuer die behandlung von narben.

Legal Events

Date Code Title Description
FG3A Patent granted, date of granting

Effective date: 19941013

MM4A Annulment/lapse due to non-payment of fees, searched and examined patent

Free format text: LAPSE DUE TO NON-PAYMENT OF FEES

Effective date: 20090413

MM4A Annulment/lapse due to non-payment of fees, searched and examined patent

Free format text: MAXIMUM VALIDITY LIMIT REACHED

Effective date: 20091013